Risk Profiles for Sensorineural Hearing Loss in Patients with Head and Neck Cancer Receiving Cisplatin-based Chemoradiation

Pignon, 2009, Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients, Radiother Oncol, 92, 4, 10.1016/j.radonc.2009.04.014 Forastiere, 2013, Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer, J Clin Oncol, 31, 845, 10.1200/JCO.2012.43.6097 Winquist, 2007, Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: a systematic review with meta-analysis, Head Neck, 29, 38, 10.1002/hed.20465 Bernier, 2004, Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer, N Eng J Med, 350, 1945, 10.1056/NEJMoa032641 Cooper, 2004, Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck, The N Eng J Med, 350, 1937, 10.1056/NEJMoa032646 Bhandare, 2010, Radiation therapy and hearing loss, Int J Radiat Oncol Biol Phys, 76, S50, 10.1016/j.ijrobp.2009.04.096 Chan, 2009, Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis, Int J Radiat Oncol Biol Phys, 73, 1335, 10.1016/j.ijrobp.2008.07.034 Pan, 2005, Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients, Int J Radiat Oncol Biol Phys, 61, 1393, 10.1016/j.ijrobp.2004.08.019 Oh, 2004, Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma, Radiother Oncol, 72, 79, 10.1016/j.radonc.2004.02.009 Zuur, 2008, Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer, Radiother Oncol, 89, 38, 10.1016/j.radonc.2008.06.003 Gillison, 2008, Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers, J Natl Cancer Inst, 100, 407, 10.1093/jnci/djn025 Eisbruch, 2011, Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates, Int J Radiat Oncol Biol Phys, 81, e93, 10.1016/j.ijrobp.2010.12.067 Shorter, 2014, Sensorineural hearing loss after treatment for head and neck cancer: a review of the literature, J Med Imaging Radiat Sci, 45, 316, 10.1016/j.jmir.2013.11.003 Raaijmakers, 2002, Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation? A systematic review of the literature, Radiother Oncol, 65, 1, 10.1016/S0167-8140(02)00211-6 Chen, 2006, Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma, Cancer, 106, 820, 10.1002/cncr.21683 Ho, 1999, Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: a prospective study, Head Neck, 21, 547, 10.1002/(SICI)1097-0347(199909)21:6<547::AID-HED8>3.0.CO;2-Y Low, 2006, Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study, J Clin Oncol, 24, 1904, 10.1200/JCO.2005.05.0096 Edwards, 2013, Personalised risk communication for informed decision making about taking screening tests, Cochrane Database Syst Rev, 2, CD001865 Pace, 2014, A systematic assessment of benefits and risks to guide breast cancer screening decisions, JAMA, 311, 1327, 10.1001/jama.2014.1398 Kwong, 1996, Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment, Int J Radiat Oncol Biol Phys, 36, 281, 10.1016/S0360-3016(96)00302-1 Bhandare, 2007, Ototoxicity after radiotherapy for head and neck tumors, Int J Radiat Oncol Biol Phys, 67, 469, 10.1016/j.ijrobp.2006.09.017 Hitchcock, 2009, Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients, Int J Radiat Oncol Biol Phys, 73, 779, 10.1016/j.ijrobp.2008.05.040 Zuur, 2009, Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors, Int J Radiat Oncol Biol Phys, 74, 490, 10.1016/j.ijrobp.2008.08.011 Petsuksiri, 2011, Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients, Radiat Oncol, 6, 19, 10.1186/1748-717X-6-19 Zuur, 2007, Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis, Int J Radiat Oncol Biol Phys, 68, 1320, 10.1016/j.ijrobp.2007.01.042 Weiss, 1970, How smoking affects hearing, Medical Times, 98, 84 Cruickshanks, 1998, Cigarette smoking and hearing loss: the epidemiology of hearing loss study, JAMA, 279, 1715, 10.1001/jama.279.21.1715 Fransen, 2008, Occupational noise, smoking, and a high body mass index are risk factors for age-related hearing impairment and moderate alcohol consumption is protective: a European population-based multicenter study, J Assoc Res Otolaryngol, 9, 264, 10.1007/s10162-008-0123-1 Dawes, 2014, Cigarette smoking, passive smoking, alcohol consumption, and hearing loss, J Assoc Res Otolaryngol, 15, 663, 10.1007/s10162-014-0461-0 Popelka, 2000, Moderate alcohol consumption and hearing loss: a protective effect, J Am Geriatr Soc, 48, 1273, 10.1111/j.1532-5415.2000.tb02601.x Walker, 1989, Enhanced cis-platinum ototoxicity in children with brain tumours who have received simultaneous or prior cranial irradiation, Med Pediatr Oncol, 17, 48, 10.1002/mpo.2950170110